Erratum: Angiotensin II-Dependent src and smad1 signaling pathway is crucial for the development of diabetic nephropathy (Laboratory Investigation (2012) 92 (797) DOI: 10.1038/labinvest.2012.7);Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI

Laboratory Investigation

Volumn 92, Issue 4, 2012, Pages 636-645

  Kadayakkara, Deepak K ^a   Ranganathan, Sarangarajan ^b   Young, Won Bin ^c   Ahrens, Eric T ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

bowel; inflammation; macrophage; MRI; perfluorocarbon

Indexed keywords

CD68 ANTIGEN; CYCLOSPORIN A; DEXAMETHASONE; FLUOROCARBON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DESCENDING COLON; DISEASE COURSE; DRUG EFFECT; ENTERITIS; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; HISTOLOGY; HYPERPLASIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

EID: 84859346455     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.79     Document Type: Erratum

References (50)

1. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642. (Pubitemid 27078848)
2. Schreyer AG, Seitz J, Feuerbach S, et al. Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD). Inflamm Bowel Dis 2004;10:45-54. (Pubitemid 38072446)
3. Dijkstra J, Reeders JW, Tytgat GN. Idiopathic inflammatory bowel disease: endoscopic-radiologic correlation. Radiology 1995;197: 369-375.
4. Sheikh SZ, Plevy SE. The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol 2010;26:578-582.
5. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12(Suppl 1):S3-S9. (Pubitemid 43068428)
6. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21-33.
7. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434. (Pubitemid 47123518)
8. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-181. (Pubitemid 23308385)
9. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52:65-70. (Pubitemid 36020767)
10. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92(12 Suppl):5S-11S.
11. Berg DJ, Davidson N, Kuhn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996;98:1010-1020. (Pubitemid 26293320)
12. Neurath MF, Fuss I, Pasparakis M, et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997;27:1743-1750. (Pubitemid 27302858)
13. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of inflammatory activity in Crohn's disease. Am J Roentgenol 2005;184:1829-1835. (Pubitemid 40770156)
14. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging 2005;4:143-164. (Pubitemid 43143788)
15. Hitchens TK, Ye Q, Eytan DF, et al. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med 2011;65:1144-1153.
16. Ebner B, Behm P, Jacoby C, et al. Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging 2010; 3:202-210.
17. Noth U, Morrissey SP, Deichmann R, et al. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol 1997;25:243-254. (Pubitemid 27267596)
18. Flogel U, Ding Z, Hardung H, et al. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008;118:140-148.
19. Flogel U, Su S, Kreideweiss I, et al. Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage. Am J Transplant 2011;11:235-244.
20. Ahrens ET, Young WB, Xu H, et al. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques 2011; 50:229-234.
21. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274. (Pubitemid 23320290)
22. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-656.
23. Schreiber S, Heinig T, Thiele HG, et al. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-1444.
24. Tedde A, Laura Putignano A, Bagnoli S, et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol 2008;43:712-718. (Pubitemid 351868712)
25. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008;40:1319-1323.
26. Weinstock JV, Blum A, Metwali A, et al. Substance P regulates Th1-type colitis in IL-10 knockout mice. J Immunol 2003;171:3762-3767. (Pubitemid 37254581)
27. Watanabe N, Ikuta K, Okazaki K, et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci 2003;48:408-414. (Pubitemid 36233012)
28. Ohkawara T, Nishihira J, Takeda H, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002;123:256-270. (Pubitemid 34747546)
29. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
30. Ahrens ET, Flores R, Xu H, et al. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005;23:983-987. (Pubitemid 41114032)
31. Srinivas M, Morel PA, Ernst LA, et al. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 2007;58:725-734. (Pubitemid 47556877)
32. Kim HW, Greenburg AG. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs 2004;28:813-828. (Pubitemid 39159154)
33. Helfer BM, Balducci A, Nelson AD, et al. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 2010;12:238-250.
34. Kadayakkara DK, Beatty PL, Turner MS, et al. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas 2010;39:510-515.
35. Janjic JM, Srinivas M, Kadayakkara DK, et al. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J Am Chem Soc 2008;130:2832-2841. (Pubitemid 351416243)
36. Ruiz-Cabello J, Walczak P, Kedziorek DA, et al. In vivo 'hot spot' MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med 2008;60:1506-1511.
37. Kadayakkara DK, Janjic JM, Pusateri LK, et al. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med 2010;64:1252-1259.
38. Partlow KC, Chen J, Brant JA, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 2007;21:1647-1654. (Pubitemid 46855610)
39. Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 2000;118(2 Suppl 1):S68-S82. (Pubitemid 30094436)
40. van Meeteren ME, Meijssen MA, Zijlstra FJ. The effect of dexamethasone treatment on murine colitis. Scand J Gastroenterol 2000;35:517-521. (Pubitemid 30354092)
41. Kojouharoff G, Hans W, Obermeier F, et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997;107:353-358. (Pubitemid 27049264)
42. Parrillo JE, Fauci AS. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 1979;19:179-201. (Pubitemid 9156577)
43. Gordon PV, Attridge JT. Understanding clinical literature relevant to spontaneous intestinal perforations. Am J Perinatol 2009;26:309-316.
44. Satoh Y, Ishiguro Y, Sakuraba H, et al. Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling. Am J Physiol Gastrointest Liver Physiol 2009;297:G514-G519.
45. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.
46. Laukemper-Ostendorf S, Scholz A, Burger K, et al. 19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation. Magn Reson Med 2002;47:82-89. (Pubitemid 34019696)
47. Ratner AV, Hurd R, Muller HH, et al. 19F magnetic resonance imaging of the reticuloendothelial system. Magn Reson Med 1987;5:548-554.
48. Neubauer AM, Caruthers SD, Hockett FD, et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson 2007;9:565-573. (Pubitemid 46399012)
49. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:993-1000. (Pubitemid 47309971)
50. Kim P, Chung E, Yamashita H, et al. In vivo wide-area cellular imaging by side-view endomicroscopy. Nat Methods 2010;7:303-305.